東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Thyroid eye disease

Douglas, Raymond S.

FindBook

Google Book

Amazon

博客來

Thyroid eye disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Thyroid eye disease/ edited by Raymond S. Douglas, Allison N. McCoy, Shivani Gupta.
其他作者:	Douglas, Raymond S.
出版者:	New York, NY :Springer New York : : 2015.,
面頁冊數:	x, 157 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Thyroid eye disease. -
電子資源:	http://dx.doi.org/10.1007/978-1-4939-1746-4
ISBN:	9781493917464 (electronic bk.)

Thyroid eye disease
Thyroid eye disease[electronic resource] /edited by Raymond S. Douglas, Allison N. McCoy, Shivani Gupta. - New York, NY :Springer New York :2015. - x, 157 p. :ill., digital ;24 cm.

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years. Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical utility. The diagnostic features of euthyroid TED are also carefully covered since these patients often represent a diagnostic dilemma. All relevant aspects of treatment are addressed including the role of radioactive iodine, long-term medical therapy, and surgical thyroidectomy. The impact of these treatment modalities on eye disease are discussed. Management of active TED is reviewed according to the severity of disease and in the light of recent findings and the introduction of novel agents. The discussion encompasses the role of steroids and other agents, the use of novel biologics, the medical and surgical treatment of optic neuropathy, and minimally invasive, customized reconstructive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.

ISBN: 9781493917464 (electronic bk.)

Standard No.: 10.1007/978-1-4939-1746-4doiSubjects--Topical Terms:

2016775
Thyroid eye disease.

LC Class. No.: RE715.T48

Dewey Class. No.: 617.7

Thyroid eye disease
LDR:02336nmm a2200301 a 4500 001 1993788
003 DE-He213
005 20150722152938.0
006 m d
007 cr nn 008maaau
008 151019s2015 nyu s 0 eng d
020 $a 9781493917464 (electronic bk.)
020 $a 9781493917457 (paper)
024 7 $a 10.1007/978-1-4939-1746-4 $2 doi
035 $a 978-1-4939-1746-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RE715.T48
072 7 $a MJQ $2 bicssc
072 7 $a MED063000 $2 bisacsh
082 0 4 $a 617.7 $2 23
090 $a RE715.T48 $b T549 2015
245 0 0 $a Thyroid eye disease $h [electronic resource] / $c edited by Raymond S. Douglas, Allison N. McCoy, Shivani Gupta.
260 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2015.
300 $a x, 157 p. : $b ill., digital ; $c 24 cm.
520 $a This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years. Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical utility. The diagnostic features of euthyroid TED are also carefully covered since these patients often represent a diagnostic dilemma. All relevant aspects of treatment are addressed including the role of radioactive iodine, long-term medical therapy, and surgical thyroidectomy. The impact of these treatment modalities on eye disease are discussed. Management of active TED is reviewed according to the severity of disease and in the light of recent findings and the introduction of novel agents. The discussion encompasses the role of steroids and other agents, the use of novel biologics, the medical and surgical treatment of optic neuropathy, and minimally invasive, customized reconstructive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.
650 0 $a Thyroid eye disease. $3 2016775
650 0 $a Medicine. $3 641104
650 0 $a Endocrinology. $3 610914
650 0 $a Ophthalmology. $3 862704
650 1 4 $a Medicine & Public Health. $3 890906
700 1 $a Douglas, Raymond S. $3 2132230
700 1 $a McCoy, Allison N. $3 2132231
700 1 $a Gupta, Shivani. $3 2132232
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-1-4939-1746-4
950 $a Medicine (Springer-11650)